Wegovy coverage through Medicaid depends entirely on which state you live in. There is no federal requirement for state Medicaid programs to cover weight loss medications, and most states currently do not. As of recent counts, only about 15 states give Medicaid enrollees access to anti-obesity medications like Wegovy for weight management. The rest either explicitly exclude these drugs or simply don’t include them on their preferred drug lists.
Why Most States Can Exclude Wegovy
Federal law has long allowed state Medicaid programs to exclude “agents when used for anorexia, weight loss, or weight gain” from their prescription drug benefits. This carve-out, written into the Social Security Act, means states are not obligated to pay for medications prescribed specifically for weight management, even when those drugs are FDA-approved. Most states have used this flexibility to keep costly obesity medications off their formularies.
This is different from how Medicaid handles most other prescription drugs. When a state chooses to offer a prescription drug benefit (all 50 states currently do), it generally must cover most FDA-approved medications. Weight loss drugs are one of the few categories that get a specific legal exemption.
A Federal Rule That Could Change Everything
The Biden administration proposed a rule that would reinterpret the federal exclusion, arguing that anti-obesity medications treat a chronic disease rather than simply promoting weight loss. Under this interpretation, Medicaid programs could no longer exclude these drugs for people with obesity. The proposal would not have extended coverage to people who are overweight but don’t meet the clinical threshold for obesity.
That rule was never finalized before the transition to the Trump administration. Whether the incoming leadership at CMS will finalize it as proposed, modify it, or withdraw it entirely remains an open question. If it does take effect, every state Medicaid program would be required to cover anti-obesity medications, dramatically expanding access for millions of enrollees. For now, though, the old exclusion still stands, and states retain the choice.
States That Do Cover It
Roughly 15 states already provide Medicaid coverage for anti-obesity medications on a voluntary basis. These states made independent decisions to include drugs like Wegovy on their formularies despite having no federal mandate to do so. Coverage details, including which specific medications are preferred and what conditions must be met, vary from state to state.
To find out whether your state covers Wegovy, the most reliable step is to call the number on the back of your Medicaid card or check your state’s Medicaid pharmacy benefits page online. If you’re enrolled through a managed care plan (as the majority of Medicaid beneficiaries are), your plan may have its own formulary that differs from the state’s fee-for-service drug list. Ask your managed care plan directly.
Prior Authorization Is Almost Always Required
Even in states that cover Wegovy, you won’t simply walk into a pharmacy and pick it up. States impose prior authorization requirements, meaning your doctor must submit documentation proving you meet specific clinical criteria before the prescription is approved. These criteria vary by state but typically focus on diagnosis, age, and related health conditions.
Texas offers a detailed example of how strict these requirements can be. There, Wegovy approval through Medicaid depends on the patient’s age and diagnosis. Adults 45 and older must have a documented diagnosis of cardiovascular disease or a liver condition called MASH (previously known as NASH) along with a diagnosis of obesity or being overweight within the past two years. Adults 18 to 44 can qualify with an obesity diagnosis alone, but patients under 18 are denied outright. In all cases, the prescriber must confirm that the patient will use Wegovy alongside a reduced-calorie diet and increased physical activity.
Texas also requires that patients not have a history of pancreatitis, gastroparesis, or certain thyroid conditions, and that they aren’t already taking another GLP-1 medication. If approved, coverage lasts for 365 days before requiring renewal. Other states with coverage will have their own versions of these clinical gates, some more restrictive and others less so.
The Cardiovascular Angle
Wegovy received FDA approval in 2024 for a second use: reducing the risk of heart attack, stroke, and cardiovascular death in adults with obesity or overweight who also have established heart disease. This matters for Medicaid coverage because the federal exclusion specifically targets drugs “used for weight loss.” When Wegovy is prescribed to reduce cardiovascular risk rather than to manage weight, the legal basis for excluding it weakens considerably.
Some states have begun covering Wegovy under this cardiovascular indication even when they don’t cover it for weight management alone. If you have documented heart disease and your doctor prescribes Wegovy to lower your cardiovascular risk, your state Medicaid program may be more likely to approve it. Your prescriber’s choice of diagnosis code on the prior authorization matters here.
What You Can Do Right Now
If you’re on Medicaid and want Wegovy, start by checking whether your state covers anti-obesity medications at all. Your state Medicaid website or a call to member services will give you a definitive answer. If coverage exists, ask your doctor to initiate the prior authorization process and make sure the application includes all required documentation, particularly BMI records, relevant diagnoses, and any comorbid conditions like heart disease or liver fibrosis that could strengthen the case.
If your state doesn’t cover Wegovy, your options are limited. Manufacturer savings cards and copay assistance programs from Novo Nordisk are generally not available to people with government insurance, including Medicaid. Novo Nordisk does operate a patient assistance program for uninsured patients, but Medicaid enrollment typically disqualifies you from that as well. Some states have separate assistance programs or may cover alternative weight management medications that are less expensive, so it’s worth asking your prescriber about other options within your state’s formulary.